DNM2 and liver disorder: We uncovered a potential therapeutic strategy for MTM1-related liver disease (i.e., DNM2 inhibition) and set the groundwork for future investigation into MTM1 liver function and into factors and triggers that may modulate the cholestatic phenotype.